ZEAL.CO Zealand Pharma A/S | DK0060257814
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 4.277.449.070 | 4.620.205.780 | 7.42% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 7,82 | 22,18 | 64.74% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 16 | 14 | 14.29% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |